NCT04164225 Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
| NCT ID | NCT04164225 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-01-21 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2020-01-21 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The long-term objective of this investigation is to identify how Qigong affects brain function in brain areas relevant to patients with chronic low back pain (cLBP), thereby setting a foundation from which to perform further clinical research.
Eligibility Criteria
Inclusion Criteria: \- Adults with chronic low back pain Exclusion Criteria: * Those with cognitive problems * Those unable to speak or understand instructions * Those who have nerve problems, fractures, or infections * Those who do not speak English * Those with severe deficit in motor imagery or in vision (both are used in MRI tasks)
Contact & Investigator
Ann Van de Winckel, PhD,MSPT,PT
PRINCIPAL INVESTIGATOR
University of Minnesota
Frequently Asked Questions
Who can join the NCT04164225 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04164225 currently recruiting?
Yes, NCT04164225 is actively recruiting participants. Contact the research team at avdwlab@umn.edu for enrollment information.
Where is the NCT04164225 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT04164225 clinical trial?
NCT04164225 is sponsored by University of Minnesota. The principal investigator is Ann Van de Winckel, PhD,MSPT,PT at University of Minnesota. The trial plans to enroll 60 participants.